PerkinElmer's Q1 Revenues Climb 14 Percent on Human Health Segment Strength | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer's first-quarter revenues rose 14 percent year over year with particular strength in its Human Health segment, the company reported after the close of the market on Thursday.

For the three months ended April 1, total revenues were $510.9 million, up from $447.2 million a year ago, and nudging past analyst estimates of $510.4 million. Organically, revenues increased 6 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.